Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals Appoints Pharmaceutical and Medical Device Veteran to Board of Directors

Published in Healthcare Finance, Tax and Law Weekly, July 18th, 2007

Accentia Biopharmaceuticals, Inc, (NASDAQ:ABPI) appointed William S. Poole to serve as a member of the Company's Board of Directors. Mr. Poole will serve as a Class III Director requiring re-election at the next annual meeting of stockholders and will bring the number of Board members to eight.

Mr. Poole's career includes over thirty years of experience in the biopharmaceutical and medical device industries. Since 2003, Mr. Poole has acted as a private consultant providing advisory services regarding overall company strategies and tactical planning to senior management of a number of companies with regards to all aspects of their business. From 1972 to early 1996, Mr....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2007-07-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry